Glenza Enzalutamide – 40 mg (1 pack / 28 capsules)

At a Glance

Brand name: Glenza

Generic name: Enzalutamide

Active ingredient: Enzalutamide

Strength & pack size: Glenza 40 mg (1 pack / 28 capsules)

Dosage form: Oral hard capsules

Main indication: Advanced and metastatic castration-resistant prostate cancer and other androgen-driven settings as indicated

Therapeutic class: Androgen receptor inhibitor

Use in therapy: Systemic oral treatment alongside ongoing androgen deprivation therapy (ADT)

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Glenza 40 mg capsules are a generic enzalutamide medicine used in the treatment of advanced and metastatic
prostate cancer. Enzalutamide is a potent oral androgen receptor inhibitor that blocks androgen-driven signalling
inside prostate cancer cells. Glenza 40 mg (1 pack / 28 capsules) provides a convenient supply of
enzalutamide 40 mg capsules that matches your specialist’s written treatment plan.

In many treatment protocols, enzalutamide is used in metastatic castration-resistant prostate cancer (mCRPC) and in other settings such as
metastatic castration-sensitive or non-metastatic castration-resistant disease, according to recognised guidelines.
Because Glenza is a generic enzalutamide product, it contains the same active ingredient as branded enzalutamide while offering more accessible pricing in USD
for long-term hormonal therapy.

A typical adult daily dose is 160 mg, often given as four Glenza 40 mg capsules once daily, although your oncology or urology team may adjust this.
The pack of Glenza 40 mg (1 pack / 28 capsules) may correspond to a seven-day supply at 160 mg per day or a longer course at reduced doses.
Treatment with Glenza enzalutamide is usually combined with continuous androgen deprivation therapy (ADT) using LHRH analogues or after surgical castration.

When you buy Glenza 40 mg online from Generic Meds Mart, you receive generic enzalutamide capsules supplied by licensed manufacturers and authorised distributors
that comply with recognised GMP standards. Discreet outer packaging protects your privacy, while original blisters and cartons preserve all product details such as strength, batch number and expiry date.

This Glenza 40 mg enzalutamide product is intended only for patients under specialist oncology or urology care.
Generic Meds Mart does not diagnose cancer or alter treatment plans; the information here supports informed discussions with your treating team about access to
generic enzalutamide capsules.

Key Uses

Glenza 40 mg enzalutamide capsules are generally used for the following indications under specialist supervision:

• Treatment of metastatic castration-resistant prostate cancer (mCRPC) alongside ongoing androgen deprivation therapy
• Treatment of metastatic castration-sensitive or non-metastatic castration-resistant prostate cancer in selected patients according to recognised guidelines
• Continuation or switch therapy in men previously treated with other hormonal agents or chemotherapy when an androgen receptor inhibitor is recommended

Your specialist will determine whether Glenza 40 mg is appropriate, how it fits into your overall treatment plan and how long
enzalutamide therapy should continue.

How Enzalutamide Works in Chemotherapy

Enzalutamide is an oral hormonal anticancer agent often grouped within modern systemic chemotherapy and targeted hormonal regimens.
Glenza 40 mg contains enzalutamide, an androgen receptor inhibitor that blocks androgen-driven signalling in
prostate cancer cells.

In androgen-dependent prostate cancer, hormones such as testosterone and dihydrotestosterone bind to androgen receptors, which then move into the cell nucleus and activate genes that promote tumour growth and survival.
Glenza enzalutamide capsules act at several stages of this process: they bind to the androgen receptor with high affinity, prevent androgen binding, reduce nuclear translocation and limit DNA binding and gene activation.
By disrupting androgen receptor signalling, Glenza 40 mg can slow tumour growth, lower PSA levels and delay complications of advanced prostate cancer.

Although more targeted than many traditional cytotoxic agents, enzalutamide still has systemic effects and can influence the nervous system, blood pressure and other organs.
Careful monitoring by an experienced oncologist or urologist is therefore essential during Glenza enzalutamide therapy.

Dosage & Administration

Glenza 40 mg enzalutamide capsules must always be taken exactly as prescribed by your specialist.
Daily dosing, treatment duration and any dose changes depend on your diagnosis, other medicines and how you tolerate therapy.

• Take Glenza capsules by mouth once daily, with or without food, at approximately the same time each day.
• Swallow Glenza 40 mg capsules whole with water; do not open, crush or chew them unless your doctor or pharmacist gives specific instructions.
• Continue concurrent androgen deprivation therapy (ADT) unless your doctor has already performed surgical castration and advised otherwise.
• Do not change your dose, skip doses or stop taking Glenza without clear guidance from your oncology or urology team.
• If you miss a dose, follow your doctor’s instructions; do not take extra capsules to compensate unless specifically advised.

Your specialist will schedule regular visits, PSA tests, blood pressure checks and other investigations to monitor your response to
Glenza enzalutamide and to adjust treatment as needed.

Precautions

Before starting Glenza 40 mg, inform your doctor about your full medical history and all medicines, supplements and herbal products you use. Important considerations include:

• History of seizures, brain injury, stroke or conditions that increase seizure risk
• Cardiovascular disease, high blood pressure, heart failure or rhythm disturbances
• Pre-existing liver impairment or significant hepatic disease
• Previous falls, fractures or conditions affecting bone strength or balance
• Use of strong CYP2C8 or CYP3A4 inhibitors or inducers and medicines with a narrow therapeutic index
• Use of over-the-counter products or herbal remedies that may interact with enzalutamide

Enzalutamide is not intended for use in women and may harm an unborn baby. Men taking Glenza 40 mg are usually advised to use effective contraception if their partner may become pregnant, both during treatment and for a period afterwards, as directed by their doctor.

Enzalutamide Side Effects

Common side effects

Many patients experience side effects when starting Glenza enzalutamide capsules, especially during the first months of therapy. Common reactions may include:

• Fatigue, low energy or general tiredness
• Hot flushes
• Increased blood pressure or worsening of existing hypertension
• Headache, dizziness or difficulty concentrating
• Back pain, joint pain or muscle discomfort
• Mild swelling of the hands, ankles or feet
• Mild diarrhea, nausea or reduced appetite

These side effects are often manageable with supportive care or adjustments in overall management, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of enzalutamide are less common but serious and require urgent medical attention. Serious reactions may include:

• Seizures, sudden loss of consciousness or unusual movements
• Severe confusion, strong headache or visual changes
• Very high blood pressure, chest pain or shortness of breath suggesting a cardiovascular event
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Repeated falls, new fractures or sudden severe bone pain

If you experience any of these serious symptoms while taking Glenza 40 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Glenza 40 mg capsules at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the capsules in their original blisters and carton until use to protect them from moisture and light.
• Keep enzalutamide capsules out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Glenza enzalutamide capsules.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Glenza 40 mg enzalutamide capsules at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Glenza 40 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic enzalutamide capsules compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist or urologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed hormonal therapy with transparent conditions and professional handling of each order.

Order Now

Glenza 40 mg enzalutamide capsules are prescription-only anticancer medicines and must be used strictly under the supervision of an experienced oncologist or urologist.
Before you order Glenza 40 mg online, ensure that you have a valid prescription or written treatment plan specifying enzalutamide, the daily dose and the intended duration of therapy.

Select Glenza 40 mg (1 pack / 28 capsules), choose the appropriate quantity, add Glenza to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your healthcare team.

Geftib Gefitinib – 250 mg (1 pack / 30 tablets)

At a Glance

Generic Name: Gefitinib

Brand Name: Geftib

Strength & Pack Size: Geftib 250 mg tablets – 1 pack / 30 tablets

Dosage Form: Oral film-coated tablets

Therapeutic Class: EGFR tyrosine kinase inhibitor, targeted anticancer therapy

Main Indication: Advanced or metastatic non-small cell lung cancer (NSCLC) with sensitising EGFR mutations as indicated

Use in Therapy: First-line or subsequent-line targeted treatment under specialist oncology guidance

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from light and moisture

Product Description

Geftib 250 mg is a generic gefitinib tablet used as targeted therapy in selected patients with advanced or metastatic
non-small cell lung cancer (NSCLC). Many NSCLC tumours, particularly adenocarcinomas, carry activating EGFR mutations that make tumour cells
highly dependent on EGFR signalling. Geftib gefitinib 250 mg tablets are designed to inhibit this pathway, helping to slow disease progression in
EGFR mutation–positive lung cancer under the care of an experienced oncology team.

Each Geftib tablet contains 250 mg gefitinib, the standard oral dose used in most gefitinib treatment protocols.
The 1 pack / 30 tablets presentation provides approximately one month of once-daily therapy for many patients, making it easy to synchronise
Geftib orders with monthly visits and imaging. As a generic gefitinib 250 mg product, Geftib offers the same active ingredient and strength as originator gefitinib
while often being more accessible in USD, which is important for long-term targeted therapy.

Geftib 250 mg gefitinib tablets are typically used in patients with advanced or metastatic NSCLC whose tumours have been confirmed to carry sensitising EGFR mutations.
In some settings, Geftib gefitinib is prescribed as first-line therapy; in others, it is used after prior systemic treatment, depending on local guidelines.
Generic Meds Mart does not design treatment; we supply Geftib 250 mg in the pack size and quantity your oncologist specifies.

Key Uses

Geftib 250 mg gefitinib tablets are generally used for the following indications under specialist supervision:

• Advanced or metastatic non-small cell lung cancer (NSCLC) with documented sensitising EGFR mutations
• First-line targeted therapy in EGFR mutation–positive NSCLC where gefitinib is recommended by current guidelines
• Subsequent-line targeted therapy in selected patients whose disease remains suitable for EGFR inhibitor treatment

Your oncology team will determine whether Geftib 250 mg is appropriate based on mutation testing, prior treatments, performance status and co-morbidities.

How Gefitinib Works in Chemotherapy

Gefitinib is a targeted anticancer medicine from the class of EGFR tyrosine kinase inhibitors.
Unlike classic cytotoxic chemotherapy, Geftib gefitinib does not directly damage DNA.
Instead, it selectively blocks the intracellular tyrosine kinase domain of the epidermal growth factor receptor (EGFR).

In EGFR mutation–positive NSCLC, constitutively active EGFR triggers downstream signalling through pathways such as RAS/RAF/MEK/ERK and PI3K/AKT, promoting tumour cell survival and proliferation.
By binding to the ATP-binding site of the EGFR tyrosine kinase, Geftib 250 mg reduces receptor phosphorylation and interrupts these downstream signals.
This decreases proliferative and anti-apoptotic signalling, making tumour cells more likely to slow growth or undergo programmed cell death.

Because EGFR is also present in normal tissues, gefitinib therapy can lead to characteristic side effects such as skin rash and diarrhea, which require regular monitoring and supportive care.

Dosage & Administration

The dose and schedule of Geftib 250 mg must always follow your oncologist’s instructions.
In many protocols, the usual adult dose is one Geftib 250 mg tablet taken once daily, but only your treating team can confirm the correct regimen for you.

• Take Geftib tablets once daily at about the same time each day, with a glass of water.
• Swallow Geftib 250 mg whole; do not crush, split or chew the tablet unless your pharmacist provides specific instructions.
• Follow your clinic’s advice on taking gefitinib with or without food and try to be consistent with your routine.
• Do not change your daily dose, stop treatment or take extra tablets without clear guidance from your oncology team.
• If you miss a dose, follow the written instructions from your treatment centre; do not double the next dose unless your doctor specifically tells you to.

Regular clinic visits, blood tests and imaging will help your doctors assess response and decide whether your Geftib 250 mg gefitinib dose should continue or be adjusted.

Precautions

Before starting Geftib 250 mg gefitinib tablets, inform your healthcare team about your full medical history and all medicines, supplements and herbal products you use. Key precautions include:

• Pre-existing liver disease or abnormal liver function tests
• History of interstitial lung disease, chronic lung conditions or unexplained breathlessness
• Concurrent use of strong CYP3A4 inducers or inhibitors that may alter gefitinib levels
• Use of gastric acid–reducing medicines that can affect gefitinib tablet absorption
• Pregnancy or breastfeeding; Geftib gefitinib is not recommended and may harm an unborn baby

Men and women of reproductive potential are usually advised to use reliable contraception during and for a period after Geftib 250 mg therapy, as directed by their oncologist.

Gefitinib Side Effects

Common side effects

Common side effects of Geftib 250 mg gefitinib tablets include:

• Acne-like skin rash on the face and upper body
• Dry skin, itching or mild redness
• Diarrhea or loose stools
• Nausea, occasional vomiting or reduced appetite
• Mild mouth sores or oral irritation
• Fatigue or low energy
• Mild elevations in liver enzymes on blood tests

These effects are often manageable with supportive care, dermatologic treatments and, when necessary, dose adjustments as decided by your oncology team.

Serious side effects

Less common but serious side effects of gefitinib require urgent medical attention and may include:

• New or worsening shortness of breath, cough and fever suggesting interstitial lung disease or severe pneumonitis
• Signs of serious liver injury: yellowing of the skin or eyes, dark urine, pale stools, persistent upper abdominal pain
• Severe or persistent diarrhea leading to dehydration
• Severe skin reactions, blistering or extensive rash
• Sudden chest pain or severe breathlessness

If you experience any of these symptoms while taking Geftib 250 mg, seek emergency medical care immediately and contact your oncology team.

Storage

• Store Geftib 250 mg gefitinib tablets at room temperature, preferably below 25 °C.
• Keep tablets in their original blisters and outer carton, protected from moisture and light.
• Keep all anticancer medicines out of the sight and reach of children and pets.
• Do not use Geftib after the expiry date printed on the packaging.

Ask your pharmacist how to safely dispose of unused or expired Geftib gefitinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart provides safe, structured access to key oncology medicines such as
Geftib 250 mg gefitinib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Geftib online from Generic Meds Mart, you benefit from:

• Original gefitinib 250 mg blisters and cartons from licensed suppliers
• Discreet, plain outer packaging for international delivery
• Tracked shipping options to many destinations
• Clear, structured information about Geftib gefitinib tablets to support discussions with your oncology team
• Support for ordering, payment and delivery questions

Order Now

Geftib 250 mg gefitinib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Geftib online, ensure your oncologist has confirmed an EGFR mutation–positive tumour, recommended gefitinib as part of your treatment plan and specified the daily dose and duration.

Select Geftib 250 mg (1 pack / 30 tablets), choose the quantity that matches your written plan, add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. All treatment decisions and dose adjustments must remain with your healthcare team.